Abstract
ObjectivesFocusing on gynecologic cancer, we aimed to describe the frequency of positive tumor NGS results that met ESMO 2019 recommendations for germline genetic testing (GT), receipt of germline GT and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
